| Literature DB >> 34805997 |
Sook-Lei Liew1,2, Artemis Zavaliangos-Petropulu3,4, Nicolas Schweighofer5, Neda Jahanshad4, Catherine E Lang6,7,8, Keith R Lohse9, Nerisa Banaj10, Giuseppe Barisano3,11, Lee A Baugh12,13,14,15, Anup K Bhattacharya16, Bavrina Bigjahan17, Michael R Borich18, Lara A Boyd19, Amy Brodtmann20,21, Cathrin M Buetefisch18,22,23, Winston D Byblow24, Jessica M Cassidy25, Charalambos C Charalambous26,27, Valentina Ciullo10, Adriana B Conforto28,29, Richard C Craddock30, Adrienne N Dula30, Natalia Egorova20,31, Wuwei Feng32, Kelene A Fercho33,34, Chris M Gregory32, Colleen A Hanlon35,36, Kathryn S Hayward20,37,38, Jess A Holguin1, Brenton Hordacre39, Darryl H Hwang17,40, Steven A Kautz32,41, Mohamed Salah Khlif20, Bokkyu Kim42, Hosung Kim2, Amy Kuceyeski43, Bethany Lo1, Jingchun Liu44, David Lin45, Martin Lotze46, Bradley J MacIntosh47,48, John L Margetis1, Feroze B Mohamed49, Jan Egil Nordvik50, Matthew A Petoe51,52, Fabrizio Piras10, Sharmila Raju53, Ander Ramos-Murguialday54,55, Kate P Revill56, Pamela Roberts1,57,58, Andrew D Robertson59,60, Heidi M Schambra53, Na Jin Seo32,41,61, Mark S Shiroishi4,17, Surjo R Soekadar62, Gianfranco Spalletta10,63, Cathy M Stinear64, Anisha Suri65, Wai Kwong Tang66, Gregory T Thielman67, Vincent N Thijs20,68, Daniela Vecchio10, Nick S Ward69, Lars T Westlye70,71, Carolee J Winstein5,72, George F Wittenberg73,74, Kristin A Wong75, Chunshui Yu44,76, Steven L Wolf77,78,79,80,81, Steven C Cramer58,72, Paul M Thompson4.
Abstract
Up to two-thirds of stroke survivors experience persistent sensorimotor impairments. Recovery relies on the integrity of spared brain areas to compensate for damaged tissue. Deep grey matter structures play a critical role in the control and regulation of sensorimotor circuits. The goal of this work is to identify associations between volumes of spared subcortical nuclei and sensorimotor behaviour at different timepoints after stroke. We pooled high-resolution T1-weighted MRI brain scans and behavioural data in 828 individuals with unilateral stroke from 28 cohorts worldwide. Cross-sectional analyses using linear mixed-effects models related post-stroke sensorimotor behaviour to non-lesioned subcortical volumes (Bonferroni-corrected, P < 0.004). We tested subacute (≤90 days) and chronic (≥180 days) stroke subgroups separately, with exploratory analyses in early stroke (≤21 days) and across all time. Sub-analyses in chronic stroke were also performed based on class of sensorimotor deficits (impairment, activity limitations) and side of lesioned hemisphere. Worse sensorimotor behaviour was associated with a smaller ipsilesional thalamic volume in both early (n = 179; d = 0.68) and subacute (n = 274, d = 0.46) stroke. In chronic stroke (n = 404), worse sensorimotor behaviour was associated with smaller ipsilesional putamen (d = 0.52) and nucleus accumbens (d = 0.39) volumes, and a larger ipsilesional lateral ventricle (d = -0.42). Worse chronic sensorimotor impairment specifically (measured by the Fugl-Meyer Assessment; n = 256) was associated with smaller ipsilesional putamen (d = 0.72) and larger lateral ventricle (d = -0.41) volumes, while several measures of activity limitations (n = 116) showed no significant relationships. In the full cohort across all time (n = 828), sensorimotor behaviour was associated with the volumes of the ipsilesional nucleus accumbens (d = 0.23), putamen (d = 0.33), thalamus (d = 0.33) and lateral ventricle (d = -0.23). We demonstrate significant relationships between post-stroke sensorimotor behaviour and reduced volumes of deep grey matter structures that were spared by stroke, which differ by time and class of sensorimotor measure. These findings provide additional insight into how different cortico-thalamo-striatal circuits support post-stroke sensorimotor outcomes.Entities:
Keywords: MRI; rehabilitation; sensorimotor behaviour; stroke; subcortical volumes
Year: 2021 PMID: 34805997 PMCID: PMC8598999 DOI: 10.1093/braincomms/fcab254
Source DB: PubMed Journal: Brain Commun ISSN: 2632-1297
Summary of research cohort characteristics
| Cohort ID |
| Females/Males | Median age (IQR, min–max) | Median sensorimotor score (IQR, min–max) |
|---|---|---|---|---|
| 1 | 39 | 10/29 | 61 (17, 31–80) | 0.65 (0.23, 0.0–0.9) |
| 2 | 12 | 06/06 | 70 (12, 39–85) | 0.50 (0.41, 0.2–0.7) |
| 3 | 14 | 06/08 | 60 (15, 33–85) | 0.25 (0.22, 0.1–0.6) |
| 4 | 19 | 06/13 | 44 (15, 30–68) | 0.14 (0.17, 0.0–0.5) |
| 7 | 42 | 14/28 | 56 (14, 18–80) | 0.82 (0.35, 0.4–1.0) |
| 8 | 8 | 02/06 | 62 (10, 39–75) | 0.55 (0.35, 0.0–1.0) |
| 9 | 93 | 29/64 | 70 (16, 24–88) | 1.00 (0.07, 0.0–1.0) |
| 10 | 24 | 05/19 | 59 (13, 42–74) | 1.00 (0.02, 0.7–1.0) |
| 11 | 29 | 10/19 | 57 (11, 44–71) | 1.00 (0.05, 0.1–1.0) |
| 12 | 57 | 31/26 | 71 (17, 31–97) | 0.65 (0.71, 0.0–1.0) |
| 13 | 44 | 22/22 | 72 (18, 33–91) | 0.12 (0.32, 0.0–1.0) |
| 15 | 14 | 06/08 | 57 (11, 45–74) | 0.72 (0.25, 0.4–0.8) |
| 17 | 16 | 05/11 | 59 (04, 45–68) | 0.55 (0.23, 0.2–0.7) |
| 18 | 11 | 05/06 | 59 (07, 46–73) | 0.65 (0.22, 0.5–0.9) |
| 19 | 13 | 03/10 | 62 (21, 33–74) | 0.84 (0.08, 0.8–0.9) |
| 20 | 22 | 08/14 | 70 (13, 49–79) | 0.91 (0.14, 0.3–1.0) |
| 22 | 17 | 04/13 | 59 (30, 25–72) | 0.63 (0.50, 0.0–0.8) |
| 23 | 13 | 07/06 | 58 (08, 31–90) | 0.42 (0.17, 0.3–0.8) |
| 24 | 21 | 11/10 | 63 (13, 32–78) | 0.95 (0.00, 0.6–1.0) |
| 25 | 26 | 10/16 | 65 (18, 37–88) | 0.97 (0.20, 0.0–1.0) |
| 26 | 24 | 14/10 | 49 (20, 25–71) | 0.64 (0.14, 0.3–0.8) |
| 28 | 26 | 07/19 | 62 (11, 23–75) | 0.75 (0.25, 0.3–1.0) |
| 31 | 35 | 09/26 | 58 (12, 21–86) | 0.52 (0.31, 0.2–0.9) |
| 32 | 7 | 03/04 | 62 (16, 38–72) | 0.95 (0.44, 0.2–1.0) |
| 34 | 15 | 06/09 | 58 (11, 32–80) | 0.82 (0.20, 0.6–1.0) |
| 35 | 15 | 06/09 | 64 (18, 31–83) | 0.64 (0.52, 0.2–0.9) |
| 38 | 81 | 34/47 | 66 (19, 30–89) | 0.85 (0.60, 0.0–1.0) |
| 41 | 91 | 33/58 | 70 (15, 32–89) | 1.00 (0.02, 0.8–1.0) |
| Total | 828 | 312/516 | 63 (19, 18–97) | 0.82 (0.48, 0–1) |
Age and sensorimotor behavioural score data are shown as median [interquartile range (IQR), minimum–maximum values].
Relationships between non-lesioned subcortical volumes and sensorimotor behaviour in subacute and early stroke
| Subacute and early stroke | ||||||||
|---|---|---|---|---|---|---|---|---|
| Brain region |
| Beta (CI) | SE | df |
|
|
| Significant covariates |
| Subacute stroke (≤90 days) | ||||||||
| Ipsilesional | ||||||||
| Caudate | 194 | −0.01 (−0.51 to 0.48) | 0.25 | 180 | −0.06 | 0.954 | −0.01 | ICV |
| Lateral ventricle | 274 | 0.18 (−0.14 to 0.51) | 0.16 | 259 | 1.13 | 0.258 | 0.14 | Age, ICV |
| Nucleus accumbens | 245 | 0.24 (−0.14 to 0.62) | 0.19 | 231 | 1.26 | 0.210 | 0.17 | Age |
| Pallidum | 223 | 0.21 (−0.26 to 0.67) | 0.24 | 209 | 0.87 | 0.387 | 0.12 | ICV |
| Putamen | 201 | 0.39 (−0.09 to 0.88) | 0.25 | 187 | 1.61 | 0.109 | 0.24 | Age, ICV |
| |
|
|
|
|
|
|
|
|
| Contralesional | ||||||||
| Caudate | 219 | 0.22 (−0.20 to 0.64) | 0.21 | 205 | 1.04 | 0.298 | 0.15 | ICV |
| Lateral ventricle | 274 | 0.15 (−0.18 to 0.49) | 0.17 | 259 | 0.92 | 0.361 | 0.11 | Age, ICV |
| Nucleus accumbens | 253 | 0.15 (−0.23 to 0.52) | 0.19 | 239 | 0.77 | 0.443 | 0.10 | Age, ICV |
| Pallidum | 250 | 0.50 (0.07–0.92) | 0.22 | 236 | 2.30 | 0.022 | 0.30 | ICV |
| Putamen | 229 | 0.37 (−0.05 to 0.79) | 0.21 | 215 | 1.75 | 0.081 | 0.24 | Age, ICV |
| Thalamus | 217 | 0.09 (−0.33 to 0.50) | 0.21 | 204 | 0.41 | 0.679 | 0.06 | Age, ICV |
| Early stroke (≤21 days) | ||||||||
| Ipsilesional | ||||||||
| Caudate | 135 | −0.09 (−0.67 to 0.48) | 0.29 | 125 | −0.32 | 0.749 | −0.06 | ICV |
| Lateral ventricle | 182 | 0.25 (−0.11 to 0.61) | 0.18 | 172 | 1.37 | 0.173 | 0.21 | Age, ICV |
| Nucleus accumbens | 165 | 0.19 (−0.23 to 0.60) | 0.21 | 155 | 0.90 | 0.369 | 0.14 | Age |
| Pallidum | 157 | 0.12 (−0.39 to 0.63) | 0.26 | 147 | 0.46 | 0.644 | 0.08 | ICV |
| Putamen | 143 | 0.25 (−0.28 to 0.79) | 0.27 | 133 | 0.93 | 0.354 | 0.16 | Age, ICV |
| |
|
|
|
|
|
|
|
|
| Contralesional | ||||||||
| Caudate | 147 | 0.17 (−0.29 to 0.64) | 0.24 | 137 | 0.74 | 0.461 | 0.13 | ICV |
| Lateral ventricle | 182 | 0.19 (−0.20 to 0.57) | 0.19 | 172 | 0.96 | 0.337 | 0.15 | Age, ICV |
| Nucleus accumbens | 170 | 0.30 (−0.09 to 0.69) | 0.20 | 160 | 1.53 | 0.127 | 0.24 | Age |
| Pallidum | 171 | 0.65 (0.19–1.11) | 0.23 | 161 | 2.79 | 0.006 | 0.44 | ICV |
| Putamen | 158 | 0.26 (−0.21 to 0.72) | 0.24 | 148 | 1.10 | 0.274 | 0.18 | Age, ICV |
| Thalamus | 150 | 0.20 (−0.28 to 0.67) | 0.24 | 141 | 0.82 | 0.411 | 0.14 | Age, ICV |
Results from linear mixed-effects models of individuals with subacute stroke (top) and early stroke (bottom). Results in bold indicate significance with a Bonferroni correction for multiple comparisons (P < 0.004). The beta coefficient for sensorimotor behaviour (beta) with 95% confidence interval (CI), along with the sample size (n), standard error (SE), degrees of freedom (df), standardized effect size (d), t-value and uncorrected P-value are reported, in addition to significant fixed covariates, including age, sex and intracranial volume (ICV).
Figure 1Relationships between post-stroke sensorimotor behaviour and non-lesioned subcortical volumes. Non-lesioned subcortical regions (D, bottom right) that relate to sensorimotor behaviour from linear mixed-effects models of people with subacute (A, top left) and chronic (B, bottom left) stroke. Non-lesioned subcortical volume relationships with chronic sensorimotor impairment are shown in C (top right). There were no significant volume relationships with chronic activity limitations. Colours represent the beta estimate (β) for sensorimotor behaviour from each model. Warmer colours represent stronger positive relationships (e.g. larger brain volumes relate to better behaviour), and cooler colours represent stronger negative relationships (e.g. larger brain volumes relate to worse behaviour).
Relationships between non-lesioned subcortical volumes and sensorimotor behaviour in chronic stroke
| Chronic stroke | ||||||||
|---|---|---|---|---|---|---|---|---|
| Chronic stroke (≥180 days) | ||||||||
| Brain region |
| Beta (CI) | SE | df |
|
|
| Significant covariates |
| Ipsilesional | ||||||||
| Caudate | 193 | 0.27 (−0.28 to 0.82) | 0.28 | 169 | 0.98 | 0.330 | 0.15 | ICV |
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Pallidum | 225 | 0.30 (−0.23 to 0.84) | 0.27 | 200 | 1.11 | 0.267 | 0.16 | ICV |
| |
|
|
|
|
|
|
|
|
| Thalamus | 169 | 0.08 (−0.60 to 0.75) | 0.34 | 146 | 0.22 | 0.827 | 0.04 | Age |
| Contralesional | ||||||||
| Caudate | 345 | 0.08 (−0.31 to 0.48) | 0.20 | 320 | 0.41 | 0.679 | 0.05 | ICV |
| Lateral ventricle | 404 | −0.39 (−0.70 to 0.07) | 0.16 | 378 | −2.42 | 0.016 | −0.25 | Age, ICV |
| Nucleus accumbens | 344 | 0.21 (−0.22 to 0.65) | 0.22 | 319 | 0.96 | 0.339 | 0.11 | Age |
| Pallidum | 359 | 0.20 (−0.20 to 0.60) | 0.20 | 334 | 0.97 | 0.332 | 0.11 | Sex, ICV |
| Putamen | 355 | 0.21 (−0.18 to 0.60) | 0.20 | 330 | 1.06 | 0.291 | 0.12 | Age, ICV |
| Thalamus | 329 | −0.24 (−0.60 to 0.12) | 0.18 | 304 | −1.29 | 0.196 | −0.15 | Age, ICV |
Results from linear mixed-effects models of individuals with chronic stroke. Results in bold indicate significance with a Bonferroni correction for multiple comparisons (P < 0.004). The beta coefficient for sensorimotor behaviour (beta) with 95% confidence interval (CI), along with the sample size (n), standard error (SE), degrees of freedom (df), standardized effect size (d), t-value and uncorrected P-value are reported, in addition to significant fixed covariates, including age, sex and intracranial volume (ICV).
Relationships between non-lesioned subcortical volumes and two measures of sensorimotor behaviour (impairment, activity limitations)
| Chronic sensorimotor impairment and activity limitations | ||||||||
|---|---|---|---|---|---|---|---|---|
| Brain region |
| Beta (CI) | SE | df |
|
|
| Significant covariates |
| Sensorimotor impairment in chronic stroke | ||||||||
| Ipsilesional | ||||||||
| Caudate | 94 | 0.92 (−0.06 to 1.89) | 0.49 | 77 | 1.87 | 0.065 | 0.43 | ICV |
| |
|
|
|
| − |
| − |
|
| Nucleus accumbens | 171 | 0.58 (0.01–1.15) | 0.29 | 153 | 2.02 | 0.045 | 0.33 | Age |
| Pallidum | 120 | 0.76 (0.01–1.51) | 0.38 | 102 | 2.02 | 0.046 | 0.40 | – |
| |
|
|
|
|
|
|
|
|
| Thalamus | 84 | 0.33 (−0.72 to 1.38) | 0.53 | 68 | 0.62 | 0.537 | 0.15 | – |
| Contralesional | ||||||||
| Caudate | 222 | 0.06 (−0.44 to 0.57) | 0.26 | 204 | 0.25 | 0.806 | 0.03 | ICV |
| Lateral ventricle | 256 | −0.51 (−0.88 to 0.14) | 0.19 | 237 | −2.70 | 0.007 | −0.35 | Age, ICV |
| Nucleus accumbens | 222 | 0.21 (−0.31 to 0.73) | 0.26 | 204 | 0.80 | 0.425 | 0.11 | Age |
| Pallidum | 231 | 0.20 (−0.33 to 0.73) | 0.27 | 213 | 0.74 | 0.459 | 0.10 | Sex |
| Putamen | 229 | 0.10 (−0.38 to 0.58) | 0.24 | 211 | 0.41 | 0.681 | 0.06 | Age, ICV |
| Thalamus | 211 | −0.40 (−0.88 to 0.07) | 0.24 | 193 | −1.67 | 0.096 | −0.24 | Age, ICV |
| Activity limitations in chronic stroke | ||||||||
| Ipsilesional | ||||||||
| Caudate | 52 | −0.63 (−1.80 to 0.53) | 0.58 | 44 | −1.09 | 0.280 | −0.33 | – |
| Lateral ventricle | 116 | −0.71 (−1.46 to 0.04) | 0.38 | 108 | −1.88 | 0.062 | −0.36 | Age, ICV |
| Nucleus accumbens | 86 | 0.77 (−0.31 to 1.85) | 0.54 | 78 | 1.42 | 0.159 | 0.32 | – |
| Pallidum | 64 | 0.71 (−0.25 to 1.67) | 0.48 | 56 | 1.47 | 0.146 | 0.39 | – |
| Putamen | 65 | 0.71 (−0.62 to 2.04) | 0.67 | 57 | 1.06 | 0.292 | 0.28 | – |
| Thalamus | 56 | 0.94 (−0.36 to 2.25) | 0.65 | 48 | 1.45 | 0.153 | 0.42 | – |
| Contralesional | ||||||||
| Caudate | 96 | −0.07 (−0.98 to 0.84) | 0.46 | 88 | −0.15 | 0.885 | −0.03 | – |
| Lateral ventricle | 116 | −0.72 (−1.44 to 0.01) | 0.37 | 108 | −1.95 | 0.054 | −0.38 | Age, ICV |
| Nucleus accumbens | 107 | −0.34 (−1.17 to 0.49) | 0.42 | 99 | −0.81 | 0.420 | −0.16 | Age |
| Pallidum | 103 | −0.15 (−0.98 to 0.68) | 0.42 | 95 | −0.35 | 0.728 | −0.07 | Sex |
| Putamen | 100 | 0.06 (−0.91 to 1.03) | 0.49 | 92 | 0.12 | 0.903 | 0.03 | Age |
| Thalamus | 92 | 0.28 (−0.51 to 1.06) | 0.39 | 84 | 0.71 | 0.482 | 0.15 | Age, ICV |
Results from linear mixed-effects models in individuals with chronic stroke of sensorimotor impairment (top) compared to activity limitations (bottom). Results in bold indicate significance with a Bonferroni correction for multiple comparisons (P < 0.004). The beta coefficient for sensorimotor impairment/activity limitations (beta) with 95% confidence interval (CI), along with the sample size (n), standard error (SE), degrees of freedom (df), standardized effect size (d), t-value, and uncorrected P-value are reported, in addition to significant fixed covariates, including age, sex and intracranial volume (ICV).